Assessment of sleep quality, anxiety, depression, and quality of life in Behçet’s disease

The Egyptian Journal of Bronchology

Table 10 Correlation of disease duration, disease severity, VDI, and BDCAF with other parameters for Behçet’s Disease group (n = 30)

	Disease Duration		Clinical Severity Score		VDI		BDCAF
	r	P	r	P	r	P	R	P
Age	0.461	0.010*	-0.087	0.649	-0.019	0.922	-0.118	0.053
ESR	0.236	0.209	0.817	< 0.001*	0.708	< 0.001*	0.831	< 0.001*
CRP	0.396	0.030*	0.807	< 0.001*	0.633	< 0.001*	0.845	< 0.001*
SpO2	-0.484	0.007*	-0.540	0.002*	-0.353	0.070	-0.571	0.001*
HAM-A	0.255	0.137	0.791	< 0.001*	0.574	0.001*	0.828	< 0.001*
HAM-D	0.236	0.210	0.740	< 0.001*	0.546	0.002*	0.819	< 0.001*
ISI	0.017	0.929	0.174	0.250	0.273	0.144	0.214	0.256
ESS	0.030	0.876	0.359	0.182	0.164	0.368	0.364	0.048*
Disease duration	––	––	0.267	0.153	0.233	0.214	0.288	0.122
Clinical severity	0.267	0.153	––	––	0.768	< 0.001*	0.935	< 0.001*
VDI	0.233	0.214	0.786	< 0.001*	––	––	0.816	< 0.001*
BDCAF	0.288	0.122	0.935	< 0.001*	0.816	< 0.001*	––	––

Correlation for variables in the study was determined with spearman’s correlation. r: Correlation coefficient rho. P-value: was significant if < 0.05. ESR: erythrocyte sedimentation rate, CRP C-reactive protein, SpO₂ Oxygen saturation, MMSE: Mini-Mental state examination, HAM-A Hamilton anxiety rating scale, HAM-D Hamilton depression rating scale, ISI insomnia severity index, ESS Epworth sleepiness scale, Clinical Severity score Krause’s Behçet’s disease activity assessment, VDI Vasculitis damage index, BDCAF Behçet's Disease Current Activity Form
*Significant difference in P-value